Stock Quality:
Last 7 days
58.7%
Last 30 days
262.8%
Last 90 days
-7.0%
Trailing 12 Months
-48.5%
RNAZ RSI Chart
Growth
Profitability
Size
Dilution Risk
Balance Sheet
Momentum
Funds Popularity
Insider Trading
Historical Charts for Stock Metrics
Year | Q1 | Q2 | Q3 | Q4 |
---|---|---|---|---|
2024 | 870.7K | 81.7K | 66.3K | 0 |
2023 | 1.5M | 1.9M | 1.3M | 923.0K |
2022 | 0 | 545.7K | 813.1K | 1.1M |
2021 | 0 | 0 | 0 | 278.3K |
CEO | Mr. Robert Michael Dudley |
---|---|
WEBSITE | transcodetherapeutics.com |
SECTOR | Healthcare |
INDUSTRY | Biotechnology |
EMPLOYEES | 19 |